● Recruiting

Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

Condition: Lymphoma · Sponsor: M.D. Anderson Cancer Center

PhaseNA

Planned participants517

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

To test the feasibility of collecting cell-free DNA (cfDNA) samples from DLBCL patients before and after treatment. cfDNA is DNA traveling in your blood outside of a cell and is easily collected from blood samples drawn using the vein puncture method.

This description comes directly from the study's public registry record.

Talk to the study team

Chijioke Nze, MD · 832-729-1752 · CCNze@mdanderson.org

Always discuss trial participation with your own doctor first.

Locations (2)

MD Anderson Cancer Center	Houston, Texas, United States	Recruiting
Cancer Therapy and Research Center at The UT Health Science Center at San Antonio	San Antonio, Texas, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05676450